Our Strategy
As a non-profit association which brings together industry and academic stakeholders, the PRI employs a collaborative approach to developing and sharing Regulatory Science expertise for the development of microbiome-based medicinal products.
Regulatory Science Center
Mission
Objective
Our Membership Packages
Partnering Membership
Active Support
Active support in identifying potential partnerships
Annual Event
Invitation to annual exclusive Member Event for Partnering + Innovation Showcase
Task Groups
PRI Task Groups* (Non-regulatory topics only)
Digital Promotion
Promotion on PRI website (logo, blog articles, newsletters) & social media (LinkedIn, Twitter)
Discounted Rates
Discounted Rate (up to 20%) to attend + advantages for sponsoring at the annual Pharmabiotics Conference & Partnering event
Regulatory Membership
*Includes all advantages of Partnering Membership
On-site Workshops
Customized on-site workshops with our regulatory affairs experts to de-risk and accelerate your product development
Unique Expertise
PRI internal guidelines & previous scientific advice intelligence
Task Groups
All PRI Task Groups (regulatory & technical). These ad-hoc working groups focus on the most pressing questions facing the industry – eg. ‘Clinical Studies’, ‘Analytics’, ‘Safety’, ‘Inactivated Cells’…
Future Outlook
Foresight of future regulatory challenges
Regulatory Strategy
PRI regulatory strategy (EMA Scientific Advice Request dossier results) – the ‘overview effect’
Keeping Up
Valuable Insight
Actively provide you with a unique understanding of the authorities’ mindset/approach to microbiome-based products (LBPs/MMPs)